Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices
The CEO of Novo Nordisk did not commit to lowering the prices of Ozempic and Wegovi during a Senate hearing on Tuesday, despite repeated pressure from Sen. Bernie Sanders (I-VT), chairman of the Senate Health, Education, Labor and Pensions Committee. Novo Nordisk CEO Lars Fruagaard Jorgensen told senators on Tuesday that pharmacy benefit managers (PBMs), […]
Nvidia, Novo Nordisk, Trump Media rise premarket; SolarEdge, Pool fall By Investing.com – Investing.com
Investing.com — U.S. stocks were mixed on Tuesday, with tech stocks rebounding after a sharp sell-off the previous day. The biggest movers in U.S. pre-market trading today were: NVIDIA (NASDAQ:) shares rose 2.3%, rebounding after the chipmaker fell about 7% in the previous trading day and helping push its market capitalization back above the $3 […]
Sanders drops subpoena effort after Novo Nordisk CEO agrees to testify
Sen. Bernie Sanders (I-VT) on Friday dropped his request for subpoenas of drug company executives after the CEOs agreed to testify before the Senate later this year. Sanders announced earlier this week that he would vote on a subpoena for Novo Nordisk’s executive vice president of North American operations, Doug Langa, after the company “repeatedly […]
Sanders drops subpoena threat against Novo Nordisk
health care Full text Republican Rep. McMorris Rodgers proposes reforms to strengthen NIH Rep. Cathy McMorris Rodgers (D-Wash.), Republican chairwoman of the Energy and Commerce Committee, has released a series of proposals aimed at reforming the National Institutes of Health (NIH) to help the U.S. “maintain an innovative advantage” over its adversaries. The proposals […]
Ozempic maker Novo Nordisk surpassesTesla with $566B market value
Novo Nordisk surpassed Tesla in market valuation on Thursday after popular weight-loss drug makers Wigovy and Ozempic announced positive data in early trials of their long-awaited new obesity drug. Shares soared more than 8% to an all-time high after investors were informed that participants in a Phase I trial of a tablet version of the […]
Novo Nordisk parent buys US drug firm for $16.5bn to expand Wegovy supply | Pharmaceuticals industry
The explosion in demand for the weight-loss drug Wegoby has prompted the holding company of its maker, Novo Nordisk, to buy the US-based drug giant for $16.5 billion ($12.70) and end its production capacity. Novo Holdings has acquired New Jersey-based pharmaceutical company Catalent, which it plans to immediately sell three of its locations in the […]
Ozempic and Wegovy maker Novo Nordisk now worth $500B
The soaring popularity of weight-loss drugs Ozempic and Wigovy has pushed parent company Novo Nordisk’s valuation past the $5 trillion threshold, according to the report. The Danish drug company, which originally sold the drug as a treatment for diabetes, was valued at $506 billion. According to CNBCanalyzed data from the London Stock Exchange Group. Novo […]